nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—IKBKB—Acetylsalicylic acid—coronary artery disease	0.124	0.517	CbGbCtD
Mesalazine—MPO—coronary artery disease	0.109	0.442	CbGaD
Mesalazine—PPARG—coronary artery disease	0.0968	0.392	CbGaD
Mesalazine—Salicylate-sodium—Acetylsalicylic acid—coronary artery disease	0.0925	0.319	CrCrCtD
Mesalazine—Salicylic acid—Niacin—coronary artery disease	0.0877	0.303	CrCrCtD
Mesalazine—PPARG—Telmisartan—coronary artery disease	0.0828	0.346	CbGbCtD
Mesalazine—Salicylamide—Acetylsalicylic acid—coronary artery disease	0.0564	0.195	CrCrCtD
Mesalazine—Salicylic acid—Acetylsalicylic acid—coronary artery disease	0.0531	0.183	CrCrCtD
Mesalazine—PTGS2—coronary artery disease	0.0409	0.166	CbGaD
Mesalazine—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0178	0.0742	CbGbCtD
Mesalazine—PTGS1—Acetylsalicylic acid—coronary artery disease	0.015	0.0626	CbGbCtD
Mesalazine—MPO—artery—coronary artery disease	0.00117	0.0712	CbGeAlD
Mesalazine—PPARG—artery—coronary artery disease	0.00104	0.0632	CbGeAlD
Mesalazine—MPO—endothelium—coronary artery disease	0.000989	0.0602	CbGeAlD
Mesalazine—CHUK—heart—coronary artery disease	0.000905	0.055	CbGeAlD
Mesalazine—PPARG—endothelium—coronary artery disease	0.000878	0.0534	CbGeAlD
Mesalazine—CHUK—cardiovascular system—coronary artery disease	0.000854	0.0519	CbGeAlD
Mesalazine—CHUK—blood—coronary artery disease	0.000675	0.0411	CbGeAlD
Mesalazine—MPO—myocardium—coronary artery disease	0.000618	0.0376	CbGeAlD
Mesalazine—IKBKB—heart—coronary artery disease	0.000615	0.0374	CbGeAlD
Mesalazine—IKBKB—cardiovascular system—coronary artery disease	0.00058	0.0353	CbGeAlD
Mesalazine—PTGS1—artery—coronary artery disease	0.000555	0.0338	CbGeAlD
Mesalazine—PPARG—myocardium—coronary artery disease	0.000548	0.0333	CbGeAlD
Mesalazine—PTGS2—artery—coronary artery disease	0.000531	0.0323	CbGeAlD
Mesalazine—ALOX5—heart—coronary artery disease	0.00051	0.031	CbGeAlD
Mesalazine—ALOX5—cardiovascular system—coronary artery disease	0.000481	0.0293	CbGeAlD
Mesalazine—PTGS1—endothelium—coronary artery disease	0.000469	0.0285	CbGeAlD
Mesalazine—IKBKB—blood—coronary artery disease	0.000459	0.0279	CbGeAlD
Mesalazine—PTGS2—endothelium—coronary artery disease	0.000448	0.0273	CbGeAlD
Mesalazine—MPO—heart—coronary artery disease	0.000431	0.0262	CbGeAlD
Mesalazine—MPO—cardiovascular system—coronary artery disease	0.000407	0.0248	CbGeAlD
Mesalazine—PPARG—heart—coronary artery disease	0.000383	0.0233	CbGeAlD
Mesalazine—ALOX5—blood—coronary artery disease	0.00038	0.0231	CbGeAlD
Mesalazine—PPARG—cardiovascular system—coronary artery disease	0.000361	0.022	CbGeAlD
Mesalazine—MPO—blood—coronary artery disease	0.000322	0.0196	CbGeAlD
Mesalazine—PTGS1—myocardium—coronary artery disease	0.000293	0.0178	CbGeAlD
Mesalazine—PPARG—blood—coronary artery disease	0.000286	0.0174	CbGeAlD
Mesalazine—Aminosalicylic Acid—MPO—coronary artery disease	0.000229	0.14	CrCbGaD
Mesalazine—Olsalazine—PPARG—coronary artery disease	0.000216	0.132	CrCbGaD
Mesalazine—PTGS1—heart—coronary artery disease	0.000205	0.0124	CbGeAlD
Mesalazine—PTGS2—heart—coronary artery disease	0.000196	0.0119	CbGeAlD
Mesalazine—PTGS1—cardiovascular system—coronary artery disease	0.000193	0.0117	CbGeAlD
Mesalazine—PTGS2—cardiovascular system—coronary artery disease	0.000184	0.0112	CbGeAlD
Mesalazine—PTGS1—cardiac atrium—coronary artery disease	0.000175	0.0106	CbGeAlD
Mesalazine—Dopamine—SLC22A3—coronary artery disease	0.000162	0.0993	CrCbGaD
Mesalazine—PTGS1—blood—coronary artery disease	0.000153	0.00929	CbGeAlD
Mesalazine—PTGS2—blood—coronary artery disease	0.000146	0.00888	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—coronary artery disease	0.000133	0.0816	CrCbGaD
Mesalazine—Droxidopa—ADRB1—coronary artery disease	0.000113	0.069	CrCbGaD
Mesalazine—Dopamine—HTR7—coronary artery disease	0.000103	0.063	CrCbGaD
Mesalazine—Droxidopa—ADRB2—coronary artery disease	9.48e-05	0.058	CrCbGaD
Mesalazine—Olsalazine—PTGS2—coronary artery disease	9.14e-05	0.0559	CrCbGaD
Mesalazine—Dopamine—ADRB1—coronary artery disease	8.82e-05	0.054	CrCbGaD
Mesalazine—Diflunisal—PTGS2—coronary artery disease	8.59e-05	0.0526	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—coronary artery disease	8.59e-05	0.0526	CrCbGaD
Mesalazine—Diflunisal—ALB—coronary artery disease	7.66e-05	0.0468	CrCbGaD
Mesalazine—Dopamine—CYP2C19—coronary artery disease	6.39e-05	0.0391	CrCbGaD
Mesalazine—Salicylic acid—PTGS2—coronary artery disease	4.78e-05	0.0292	CrCbGaD
Mesalazine—Salicylic acid—ALB—coronary artery disease	4.26e-05	0.0261	CrCbGaD
Mesalazine—Malaise—Lisinopril—coronary artery disease	1.82e-05	0.000149	CcSEcCtD
Mesalazine—Anaphylactic shock—Ramipril—coronary artery disease	1.81e-05	0.000149	CcSEcCtD
Mesalazine—Oedema—Ramipril—coronary artery disease	1.81e-05	0.000149	CcSEcCtD
Mesalazine—Vertigo—Lisinopril—coronary artery disease	1.81e-05	0.000149	CcSEcCtD
Mesalazine—Dry mouth—Timolol—coronary artery disease	1.81e-05	0.000148	CcSEcCtD
Mesalazine—Constipation—Losartan—coronary artery disease	1.81e-05	0.000148	CcSEcCtD
Mesalazine—Pain—Losartan—coronary artery disease	1.81e-05	0.000148	CcSEcCtD
Mesalazine—Syncope—Lisinopril—coronary artery disease	1.81e-05	0.000148	CcSEcCtD
Mesalazine—Vomiting—Eplerenone—coronary artery disease	1.81e-05	0.000148	CcSEcCtD
Mesalazine—Feeling abnormal—Furosemide—coronary artery disease	1.8e-05	0.000148	CcSEcCtD
Mesalazine—Leukopenia—Lisinopril—coronary artery disease	1.8e-05	0.000148	CcSEcCtD
Mesalazine—Nausea—Fenofibrate—coronary artery disease	1.8e-05	0.000148	CcSEcCtD
Mesalazine—Pruritus—Niacin—coronary artery disease	1.8e-05	0.000148	CcSEcCtD
Mesalazine—Asthenia—Pravastatin—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Gastrointestinal pain—Furosemide—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Rash—Eplerenone—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Urticaria—Perindopril—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Hypersensitivity—Trandolapril—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Dermatitis—Eplerenone—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Diarrhoea—Valsartan—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Confusional state—Timolol—coronary artery disease	1.79e-05	0.000147	CcSEcCtD
Mesalazine—Shock—Ramipril—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Hypersensitivity—Enalapril—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Abdominal pain—Perindopril—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Body temperature increased—Perindopril—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Palpitations—Lisinopril—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Diarrhoea—Olmesartan—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Headache—Eplerenone—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Nervous system disorder—Ramipril—coronary artery disease	1.78e-05	0.000146	CcSEcCtD
Mesalazine—Thrombocytopenia—Ramipril—coronary artery disease	1.77e-05	0.000146	CcSEcCtD
Mesalazine—Oedema—Timolol—coronary artery disease	1.77e-05	0.000145	CcSEcCtD
Mesalazine—Anaphylactic shock—Timolol—coronary artery disease	1.77e-05	0.000145	CcSEcCtD
Mesalazine—Pruritus—Pravastatin—coronary artery disease	1.77e-05	0.000145	CcSEcCtD
Mesalazine—Loss of consciousness—Lisinopril—coronary artery disease	1.77e-05	0.000145	CcSEcCtD
Mesalazine—Nausea—Clopidogrel—coronary artery disease	1.77e-05	0.000145	CcSEcCtD
Mesalazine—Tachycardia—Ramipril—coronary artery disease	1.77e-05	0.000145	CcSEcCtD
Mesalazine—Skin disorder—Ramipril—coronary artery disease	1.76e-05	0.000145	CcSEcCtD
Mesalazine—Infection—Timolol—coronary artery disease	1.76e-05	0.000145	CcSEcCtD
Mesalazine—Vomiting—Simvastatin—coronary artery disease	1.76e-05	0.000144	CcSEcCtD
Mesalazine—Hypersensitivity—Telmisartan—coronary artery disease	1.76e-05	0.000144	CcSEcCtD
Mesalazine—Cough—Lisinopril—coronary artery disease	1.76e-05	0.000144	CcSEcCtD
Mesalazine—Nausea—Lovastatin—coronary artery disease	1.76e-05	0.000144	CcSEcCtD
Mesalazine—Hyperhidrosis—Ramipril—coronary artery disease	1.75e-05	0.000144	CcSEcCtD
Mesalazine—Rash—Simvastatin—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Dermatitis—Simvastatin—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Asthenia—Trandolapril—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Shock—Timolol—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Feeling abnormal—Losartan—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Urticaria—Furosemide—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Diarrhoea—Niacin—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Nervous system disorder—Timolol—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Asthenia—Enalapril—coronary artery disease	1.74e-05	0.000143	CcSEcCtD
Mesalazine—Headache—Simvastatin—coronary artery disease	1.73e-05	0.000142	CcSEcCtD
Mesalazine—Abdominal pain—Furosemide—coronary artery disease	1.73e-05	0.000142	CcSEcCtD
Mesalazine—Body temperature increased—Furosemide—coronary artery disease	1.73e-05	0.000142	CcSEcCtD
Mesalazine—Gastrointestinal pain—Losartan—coronary artery disease	1.73e-05	0.000142	CcSEcCtD
Mesalazine—Dizziness—Valsartan—coronary artery disease	1.73e-05	0.000142	CcSEcCtD
Mesalazine—Anorexia—Ramipril—coronary artery disease	1.73e-05	0.000142	CcSEcCtD
Mesalazine—Nausea—Ezetimibe—coronary artery disease	1.72e-05	0.000142	CcSEcCtD
Mesalazine—Skin disorder—Timolol—coronary artery disease	1.72e-05	0.000141	CcSEcCtD
Mesalazine—Dizziness—Olmesartan—coronary artery disease	1.72e-05	0.000141	CcSEcCtD
Mesalazine—Pruritus—Trandolapril—coronary artery disease	1.72e-05	0.000141	CcSEcCtD
Mesalazine—Chest pain—Lisinopril—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Arthralgia—Lisinopril—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Myalgia—Lisinopril—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Hyperhidrosis—Timolol—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Asthenia—Telmisartan—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Pruritus—Enalapril—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Diarrhoea—Pravastatin—coronary artery disease	1.71e-05	0.000141	CcSEcCtD
Mesalazine—Anxiety—Lisinopril—coronary artery disease	1.71e-05	0.00014	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.7e-05	0.00014	CcSEcCtD
Mesalazine—Discomfort—Lisinopril—coronary artery disease	1.69e-05	0.000139	CcSEcCtD
Mesalazine—Hypotension—Ramipril—coronary artery disease	1.69e-05	0.000139	CcSEcCtD
Mesalazine—Anorexia—Timolol—coronary artery disease	1.69e-05	0.000139	CcSEcCtD
Mesalazine—Pruritus—Telmisartan—coronary artery disease	1.69e-05	0.000139	CcSEcCtD
Mesalazine—Nausea—Eplerenone—coronary artery disease	1.69e-05	0.000138	CcSEcCtD
Mesalazine—Dizziness—Niacin—coronary artery disease	1.68e-05	0.000138	CcSEcCtD
Mesalazine—Urticaria—Losartan—coronary artery disease	1.68e-05	0.000138	CcSEcCtD
Mesalazine—Dry mouth—Lisinopril—coronary artery disease	1.68e-05	0.000138	CcSEcCtD
Mesalazine—Abdominal pain—Losartan—coronary artery disease	1.67e-05	0.000137	CcSEcCtD
Mesalazine—Body temperature increased—Losartan—coronary artery disease	1.67e-05	0.000137	CcSEcCtD
Mesalazine—Asthenia—Captopril—coronary artery disease	1.66e-05	0.000137	CcSEcCtD
Mesalazine—Diarrhoea—Trandolapril—coronary artery disease	1.66e-05	0.000136	CcSEcCtD
Mesalazine—Vomiting—Valsartan—coronary artery disease	1.66e-05	0.000136	CcSEcCtD
Mesalazine—Confusional state—Lisinopril—coronary artery disease	1.66e-05	0.000136	CcSEcCtD
Mesalazine—Diarrhoea—Enalapril—coronary artery disease	1.66e-05	0.000136	CcSEcCtD
Mesalazine—Hypotension—Timolol—coronary artery disease	1.65e-05	0.000136	CcSEcCtD
Mesalazine—Dizziness—Pravastatin—coronary artery disease	1.65e-05	0.000136	CcSEcCtD
Mesalazine—Vomiting—Olmesartan—coronary artery disease	1.65e-05	0.000136	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.65e-05	0.000136	CcSEcCtD
Mesalazine—Rash—Valsartan—coronary artery disease	1.65e-05	0.000135	CcSEcCtD
Mesalazine—Dermatitis—Valsartan—coronary artery disease	1.65e-05	0.000135	CcSEcCtD
Mesalazine—Nausea—Simvastatin—coronary artery disease	1.64e-05	0.000135	CcSEcCtD
Mesalazine—Oedema—Lisinopril—coronary artery disease	1.64e-05	0.000135	CcSEcCtD
Mesalazine—Anaphylactic shock—Lisinopril—coronary artery disease	1.64e-05	0.000135	CcSEcCtD
Mesalazine—Pruritus—Captopril—coronary artery disease	1.64e-05	0.000135	CcSEcCtD
Mesalazine—Rash—Olmesartan—coronary artery disease	1.64e-05	0.000135	CcSEcCtD
Mesalazine—Insomnia—Ramipril—coronary artery disease	1.64e-05	0.000135	CcSEcCtD
Mesalazine—Dermatitis—Olmesartan—coronary artery disease	1.64e-05	0.000134	CcSEcCtD
Mesalazine—Headache—Valsartan—coronary artery disease	1.64e-05	0.000134	CcSEcCtD
Mesalazine—Diarrhoea—Telmisartan—coronary artery disease	1.63e-05	0.000134	CcSEcCtD
Mesalazine—Infection—Lisinopril—coronary artery disease	1.63e-05	0.000134	CcSEcCtD
Mesalazine—Headache—Olmesartan—coronary artery disease	1.63e-05	0.000134	CcSEcCtD
Mesalazine—Paraesthesia—Ramipril—coronary artery disease	1.63e-05	0.000134	CcSEcCtD
Mesalazine—Shock—Lisinopril—coronary artery disease	1.62e-05	0.000133	CcSEcCtD
Mesalazine—Asthenia—Perindopril—coronary artery disease	1.62e-05	0.000133	CcSEcCtD
Mesalazine—Dyspnoea—Ramipril—coronary artery disease	1.62e-05	0.000133	CcSEcCtD
Mesalazine—Vomiting—Niacin—coronary artery disease	1.61e-05	0.000133	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Timolol—coronary artery disease	1.61e-05	0.000133	CcSEcCtD
Mesalazine—Hypersensitivity—Furosemide—coronary artery disease	1.61e-05	0.000132	CcSEcCtD
Mesalazine—Somnolence—Ramipril—coronary artery disease	1.61e-05	0.000132	CcSEcCtD
Mesalazine—Thrombocytopenia—Lisinopril—coronary artery disease	1.61e-05	0.000132	CcSEcCtD
Mesalazine—Dizziness—Trandolapril—coronary artery disease	1.61e-05	0.000132	CcSEcCtD
Mesalazine—Tachycardia—Lisinopril—coronary artery disease	1.6e-05	0.000132	CcSEcCtD
Mesalazine—Insomnia—Timolol—coronary artery disease	1.6e-05	0.000132	CcSEcCtD
Mesalazine—Rash—Niacin—coronary artery disease	1.6e-05	0.000132	CcSEcCtD
Mesalazine—Dermatitis—Niacin—coronary artery disease	1.6e-05	0.000131	CcSEcCtD
Mesalazine—Dizziness—Enalapril—coronary artery disease	1.6e-05	0.000131	CcSEcCtD
Mesalazine—Skin disorder—Lisinopril—coronary artery disease	1.6e-05	0.000131	CcSEcCtD
Mesalazine—Dyspepsia—Ramipril—coronary artery disease	1.59e-05	0.000131	CcSEcCtD
Mesalazine—Pruritus—Perindopril—coronary artery disease	1.59e-05	0.000131	CcSEcCtD
Mesalazine—Headache—Niacin—coronary artery disease	1.59e-05	0.000131	CcSEcCtD
Mesalazine—Paraesthesia—Timolol—coronary artery disease	1.59e-05	0.000131	CcSEcCtD
Mesalazine—Vomiting—Pravastatin—coronary artery disease	1.59e-05	0.000131	CcSEcCtD
Mesalazine—Hyperhidrosis—Lisinopril—coronary artery disease	1.59e-05	0.00013	CcSEcCtD
Mesalazine—Diarrhoea—Captopril—coronary artery disease	1.59e-05	0.00013	CcSEcCtD
Mesalazine—Dyspnoea—Timolol—coronary artery disease	1.58e-05	0.00013	CcSEcCtD
Mesalazine—Dizziness—Telmisartan—coronary artery disease	1.58e-05	0.00013	CcSEcCtD
Mesalazine—Rash—Pravastatin—coronary artery disease	1.58e-05	0.00013	CcSEcCtD
Mesalazine—Dermatitis—Pravastatin—coronary artery disease	1.58e-05	0.000129	CcSEcCtD
Mesalazine—Decreased appetite—Ramipril—coronary artery disease	1.57e-05	0.000129	CcSEcCtD
Mesalazine—Somnolence—Timolol—coronary artery disease	1.57e-05	0.000129	CcSEcCtD
Mesalazine—Asthenia—Furosemide—coronary artery disease	1.57e-05	0.000129	CcSEcCtD
Mesalazine—Headache—Pravastatin—coronary artery disease	1.57e-05	0.000129	CcSEcCtD
Mesalazine—Anorexia—Lisinopril—coronary artery disease	1.57e-05	0.000129	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Ramipril—coronary artery disease	1.56e-05	0.000128	CcSEcCtD
Mesalazine—Fatigue—Ramipril—coronary artery disease	1.56e-05	0.000128	CcSEcCtD
Mesalazine—Dyspepsia—Timolol—coronary artery disease	1.56e-05	0.000128	CcSEcCtD
Mesalazine—Hypersensitivity—Losartan—coronary artery disease	1.56e-05	0.000128	CcSEcCtD
Mesalazine—Nausea—Valsartan—coronary artery disease	1.55e-05	0.000127	CcSEcCtD
Mesalazine—Pruritus—Furosemide—coronary artery disease	1.55e-05	0.000127	CcSEcCtD
Mesalazine—Constipation—Ramipril—coronary artery disease	1.55e-05	0.000127	CcSEcCtD
Mesalazine—Nausea—Olmesartan—coronary artery disease	1.54e-05	0.000127	CcSEcCtD
Mesalazine—Vomiting—Trandolapril—coronary artery disease	1.54e-05	0.000127	CcSEcCtD
Mesalazine—Diarrhoea—Perindopril—coronary artery disease	1.54e-05	0.000127	CcSEcCtD
Mesalazine—Decreased appetite—Timolol—coronary artery disease	1.54e-05	0.000126	CcSEcCtD
Mesalazine—Vomiting—Enalapril—coronary artery disease	1.54e-05	0.000126	CcSEcCtD
Mesalazine—Hypotension—Lisinopril—coronary artery disease	1.54e-05	0.000126	CcSEcCtD
Mesalazine—Dizziness—Captopril—coronary artery disease	1.53e-05	0.000126	CcSEcCtD
Mesalazine—Rash—Trandolapril—coronary artery disease	1.53e-05	0.000126	CcSEcCtD
Mesalazine—Dermatitis—Trandolapril—coronary artery disease	1.53e-05	0.000126	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Timolol—coronary artery disease	1.53e-05	0.000126	CcSEcCtD
Mesalazine—Fatigue—Timolol—coronary artery disease	1.53e-05	0.000125	CcSEcCtD
Mesalazine—Rash—Enalapril—coronary artery disease	1.53e-05	0.000125	CcSEcCtD
Mesalazine—Dermatitis—Enalapril—coronary artery disease	1.52e-05	0.000125	CcSEcCtD
Mesalazine—Headache—Trandolapril—coronary artery disease	1.52e-05	0.000125	CcSEcCtD
Mesalazine—Vomiting—Telmisartan—coronary artery disease	1.52e-05	0.000125	CcSEcCtD
Mesalazine—Asthenia—Losartan—coronary artery disease	1.52e-05	0.000124	CcSEcCtD
Mesalazine—Headache—Enalapril—coronary artery disease	1.52e-05	0.000124	CcSEcCtD
Mesalazine—Pain—Timolol—coronary artery disease	1.51e-05	0.000124	CcSEcCtD
Mesalazine—Nausea—Niacin—coronary artery disease	1.51e-05	0.000124	CcSEcCtD
Mesalazine—Rash—Telmisartan—coronary artery disease	1.5e-05	0.000124	CcSEcCtD
Mesalazine—Dermatitis—Telmisartan—coronary artery disease	1.5e-05	0.000123	CcSEcCtD
Mesalazine—Diarrhoea—Furosemide—coronary artery disease	1.5e-05	0.000123	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.5e-05	0.000123	CcSEcCtD
Mesalazine—Pruritus—Losartan—coronary artery disease	1.49e-05	0.000123	CcSEcCtD
Mesalazine—Headache—Telmisartan—coronary artery disease	1.49e-05	0.000123	CcSEcCtD
Mesalazine—Feeling abnormal—Ramipril—coronary artery disease	1.49e-05	0.000123	CcSEcCtD
Mesalazine—Dizziness—Perindopril—coronary artery disease	1.49e-05	0.000122	CcSEcCtD
Mesalazine—Insomnia—Lisinopril—coronary artery disease	1.49e-05	0.000122	CcSEcCtD
Mesalazine—Nausea—Pravastatin—coronary artery disease	1.49e-05	0.000122	CcSEcCtD
Mesalazine—Gastrointestinal pain—Ramipril—coronary artery disease	1.48e-05	0.000122	CcSEcCtD
Mesalazine—Paraesthesia—Lisinopril—coronary artery disease	1.48e-05	0.000121	CcSEcCtD
Mesalazine—Vomiting—Captopril—coronary artery disease	1.48e-05	0.000121	CcSEcCtD
Mesalazine—Dyspnoea—Lisinopril—coronary artery disease	1.46e-05	0.00012	CcSEcCtD
Mesalazine—Rash—Captopril—coronary artery disease	1.46e-05	0.00012	CcSEcCtD
Mesalazine—Dermatitis—Captopril—coronary artery disease	1.46e-05	0.00012	CcSEcCtD
Mesalazine—Somnolence—Lisinopril—coronary artery disease	1.46e-05	0.00012	CcSEcCtD
Mesalazine—Feeling abnormal—Timolol—coronary artery disease	1.46e-05	0.00012	CcSEcCtD
Mesalazine—Headache—Captopril—coronary artery disease	1.45e-05	0.000119	CcSEcCtD
Mesalazine—Gastrointestinal pain—Timolol—coronary artery disease	1.45e-05	0.000119	CcSEcCtD
Mesalazine—Dizziness—Furosemide—coronary artery disease	1.45e-05	0.000119	CcSEcCtD
Mesalazine—Dyspepsia—Lisinopril—coronary artery disease	1.45e-05	0.000119	CcSEcCtD
Mesalazine—Diarrhoea—Losartan—coronary artery disease	1.45e-05	0.000119	CcSEcCtD
Mesalazine—Nausea—Trandolapril—coronary artery disease	1.44e-05	0.000118	CcSEcCtD
Mesalazine—Urticaria—Ramipril—coronary artery disease	1.44e-05	0.000118	CcSEcCtD
Mesalazine—Nausea—Enalapril—coronary artery disease	1.44e-05	0.000118	CcSEcCtD
Mesalazine—Vomiting—Perindopril—coronary artery disease	1.43e-05	0.000118	CcSEcCtD
Mesalazine—Abdominal pain—Ramipril—coronary artery disease	1.43e-05	0.000118	CcSEcCtD
Mesalazine—Body temperature increased—Ramipril—coronary artery disease	1.43e-05	0.000118	CcSEcCtD
Mesalazine—Decreased appetite—Lisinopril—coronary artery disease	1.43e-05	0.000117	CcSEcCtD
Mesalazine—Rash—Perindopril—coronary artery disease	1.42e-05	0.000117	CcSEcCtD
Mesalazine—Dermatitis—Perindopril—coronary artery disease	1.42e-05	0.000117	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.42e-05	0.000116	CcSEcCtD
Mesalazine—Nausea—Telmisartan—coronary artery disease	1.42e-05	0.000116	CcSEcCtD
Mesalazine—Fatigue—Lisinopril—coronary artery disease	1.42e-05	0.000116	CcSEcCtD
Mesalazine—Headache—Perindopril—coronary artery disease	1.41e-05	0.000116	CcSEcCtD
Mesalazine—Urticaria—Timolol—coronary artery disease	1.41e-05	0.000116	CcSEcCtD
Mesalazine—Pain—Lisinopril—coronary artery disease	1.4e-05	0.000115	CcSEcCtD
Mesalazine—Constipation—Lisinopril—coronary artery disease	1.4e-05	0.000115	CcSEcCtD
Mesalazine—Body temperature increased—Timolol—coronary artery disease	1.4e-05	0.000115	CcSEcCtD
Mesalazine—Abdominal pain—Timolol—coronary artery disease	1.4e-05	0.000115	CcSEcCtD
Mesalazine—Dizziness—Losartan—coronary artery disease	1.4e-05	0.000115	CcSEcCtD
Mesalazine—Vomiting—Furosemide—coronary artery disease	1.39e-05	0.000114	CcSEcCtD
Mesalazine—Rash—Furosemide—coronary artery disease	1.38e-05	0.000113	CcSEcCtD
Mesalazine—Dermatitis—Furosemide—coronary artery disease	1.38e-05	0.000113	CcSEcCtD
Mesalazine—Nausea—Captopril—coronary artery disease	1.38e-05	0.000113	CcSEcCtD
Mesalazine—Headache—Furosemide—coronary artery disease	1.37e-05	0.000113	CcSEcCtD
Mesalazine—Feeling abnormal—Lisinopril—coronary artery disease	1.35e-05	0.000111	CcSEcCtD
Mesalazine—Gastrointestinal pain—Lisinopril—coronary artery disease	1.34e-05	0.00011	CcSEcCtD
Mesalazine—Vomiting—Losartan—coronary artery disease	1.34e-05	0.00011	CcSEcCtD
Mesalazine—Nausea—Perindopril—coronary artery disease	1.34e-05	0.00011	CcSEcCtD
Mesalazine—Hypersensitivity—Ramipril—coronary artery disease	1.33e-05	0.00011	CcSEcCtD
Mesalazine—Rash—Losartan—coronary artery disease	1.33e-05	0.000109	CcSEcCtD
Mesalazine—Dermatitis—Losartan—coronary artery disease	1.33e-05	0.000109	CcSEcCtD
Mesalazine—Headache—Losartan—coronary artery disease	1.32e-05	0.000109	CcSEcCtD
Mesalazine—Urticaria—Lisinopril—coronary artery disease	1.31e-05	0.000107	CcSEcCtD
Mesalazine—Hypersensitivity—Timolol—coronary artery disease	1.3e-05	0.000107	CcSEcCtD
Mesalazine—Nausea—Furosemide—coronary artery disease	1.3e-05	0.000107	CcSEcCtD
Mesalazine—Asthenia—Ramipril—coronary artery disease	1.3e-05	0.000107	CcSEcCtD
Mesalazine—Abdominal pain—Lisinopril—coronary artery disease	1.3e-05	0.000107	CcSEcCtD
Mesalazine—Body temperature increased—Lisinopril—coronary artery disease	1.3e-05	0.000107	CcSEcCtD
Mesalazine—Pruritus—Ramipril—coronary artery disease	1.28e-05	0.000105	CcSEcCtD
Mesalazine—Asthenia—Timolol—coronary artery disease	1.27e-05	0.000104	CcSEcCtD
Mesalazine—Nausea—Losartan—coronary artery disease	1.25e-05	0.000103	CcSEcCtD
Mesalazine—Pruritus—Timolol—coronary artery disease	1.25e-05	0.000103	CcSEcCtD
Mesalazine—Diarrhoea—Ramipril—coronary artery disease	1.24e-05	0.000102	CcSEcCtD
Mesalazine—Diarrhoea—Timolol—coronary artery disease	1.21e-05	9.95e-05	CcSEcCtD
Mesalazine—Hypersensitivity—Lisinopril—coronary artery disease	1.21e-05	9.94e-05	CcSEcCtD
Mesalazine—Dizziness—Ramipril—coronary artery disease	1.2e-05	9.84e-05	CcSEcCtD
Mesalazine—Asthenia—Lisinopril—coronary artery disease	1.18e-05	9.68e-05	CcSEcCtD
Mesalazine—Dizziness—Timolol—coronary artery disease	1.17e-05	9.62e-05	CcSEcCtD
Mesalazine—Pruritus—Lisinopril—coronary artery disease	1.16e-05	9.55e-05	CcSEcCtD
Mesalazine—Vomiting—Ramipril—coronary artery disease	1.15e-05	9.46e-05	CcSEcCtD
Mesalazine—Rash—Ramipril—coronary artery disease	1.14e-05	9.38e-05	CcSEcCtD
Mesalazine—Dermatitis—Ramipril—coronary artery disease	1.14e-05	9.37e-05	CcSEcCtD
Mesalazine—Headache—Ramipril—coronary artery disease	1.13e-05	9.32e-05	CcSEcCtD
Mesalazine—Vomiting—Timolol—coronary artery disease	1.13e-05	9.25e-05	CcSEcCtD
Mesalazine—Diarrhoea—Lisinopril—coronary artery disease	1.12e-05	9.23e-05	CcSEcCtD
Mesalazine—Rash—Timolol—coronary artery disease	1.12e-05	9.17e-05	CcSEcCtD
Mesalazine—Dermatitis—Timolol—coronary artery disease	1.12e-05	9.16e-05	CcSEcCtD
Mesalazine—Headache—Timolol—coronary artery disease	1.11e-05	9.11e-05	CcSEcCtD
Mesalazine—Dizziness—Lisinopril—coronary artery disease	1.09e-05	8.92e-05	CcSEcCtD
Mesalazine—Nausea—Ramipril—coronary artery disease	1.08e-05	8.84e-05	CcSEcCtD
Mesalazine—Nausea—Timolol—coronary artery disease	1.05e-05	8.64e-05	CcSEcCtD
Mesalazine—Vomiting—Lisinopril—coronary artery disease	1.04e-05	8.58e-05	CcSEcCtD
Mesalazine—Rash—Lisinopril—coronary artery disease	1.04e-05	8.51e-05	CcSEcCtD
Mesalazine—Dermatitis—Lisinopril—coronary artery disease	1.03e-05	8.5e-05	CcSEcCtD
Mesalazine—Headache—Lisinopril—coronary artery disease	1.03e-05	8.45e-05	CcSEcCtD
Mesalazine—Nausea—Lisinopril—coronary artery disease	9.76e-06	8.01e-05	CcSEcCtD
Mesalazine—PPARG—Metabolism—AGT—coronary artery disease	2.37e-06	2.8e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6R—coronary artery disease	2.36e-06	2.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP3—coronary artery disease	2.35e-06	2.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—STAT5A—coronary artery disease	2.35e-06	2.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MAPK1—coronary artery disease	2.35e-06	2.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—KIT—coronary artery disease	2.34e-06	2.78e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SERPINE1—coronary artery disease	2.34e-06	2.77e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL10—coronary artery disease	2.34e-06	2.77e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PLG—coronary artery disease	2.33e-06	2.76e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOE—coronary artery disease	2.32e-06	2.74e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KIT—coronary artery disease	2.3e-06	2.73e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOA1—coronary artery disease	2.29e-06	2.71e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOB—coronary artery disease	2.27e-06	2.69e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PSMA6—coronary artery disease	2.27e-06	2.69e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PSMB5—coronary artery disease	2.27e-06	2.69e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADRB2—coronary artery disease	2.27e-06	2.69e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.27e-06	2.68e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT1—coronary artery disease	2.27e-06	2.68e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—GSK3B—coronary artery disease	2.25e-06	2.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCE—coronary artery disease	2.24e-06	2.65e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EDN1—coronary artery disease	2.24e-06	2.65e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SOCS1—coronary artery disease	2.24e-06	2.65e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CREB1—coronary artery disease	2.23e-06	2.64e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—S100B—coronary artery disease	2.23e-06	2.64e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL5—coronary artery disease	2.22e-06	2.63e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CTGF—coronary artery disease	2.22e-06	2.63e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—GSK3B—coronary artery disease	2.21e-06	2.62e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SOCS3—coronary artery disease	2.21e-06	2.61e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMGCR—coronary artery disease	2.2e-06	2.6e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT2—coronary artery disease	2.2e-06	2.6e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.19e-06	2.6e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CREB1—coronary artery disease	2.19e-06	2.6e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF1—coronary artery disease	2.19e-06	2.59e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CSF2—coronary artery disease	2.19e-06	2.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFBR2—coronary artery disease	2.18e-06	2.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KITLG—coronary artery disease	2.18e-06	2.58e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6R—coronary artery disease	2.18e-06	2.58e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—coronary artery disease	2.17e-06	2.58e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LPL—coronary artery disease	2.17e-06	2.57e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MEF2C—coronary artery disease	2.15e-06	2.55e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RPS6KB1—coronary artery disease	2.15e-06	2.55e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTP1—coronary artery disease	2.15e-06	2.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6R—coronary artery disease	2.14e-06	2.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGF2—coronary artery disease	2.14e-06	2.53e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STAT5A—coronary artery disease	2.13e-06	2.53e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP3—coronary artery disease	2.13e-06	2.53e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MAPK1—coronary artery disease	2.13e-06	2.52e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARGC1A—coronary artery disease	2.13e-06	2.52e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—HMOX1—coronary artery disease	2.12e-06	2.51e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ITGB3—coronary artery disease	2.1e-06	2.48e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCE—coronary artery disease	2.09e-06	2.48e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CAT—coronary artery disease	2.09e-06	2.47e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOB—coronary artery disease	2.06e-06	2.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—JAK2—coronary artery disease	2.05e-06	2.43e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—SERPINE1—coronary artery disease	2.04e-06	2.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PIK3CA—coronary artery disease	2.04e-06	2.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PPP2CA—coronary artery disease	2.04e-06	2.41e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KITLG—coronary artery disease	2.04e-06	2.41e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFBR2—coronary artery disease	2.04e-06	2.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—BCL2—coronary artery disease	2.03e-06	2.4e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOB—coronary artery disease	2.03e-06	2.4e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EDN1—coronary artery disease	2.03e-06	2.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PLCB1—coronary artery disease	2.02e-06	2.39e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL5—coronary artery disease	2.01e-06	2.38e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—AKT1—coronary artery disease	2.01e-06	2.38e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PRKCD—coronary artery disease	2e-06	2.37e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—POMC—coronary artery disease	1.99e-06	2.36e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—STAT5A—coronary artery disease	1.99e-06	2.36e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CSF2—coronary artery disease	1.98e-06	2.35e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF1—coronary artery disease	1.98e-06	2.35e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGF2—coronary artery disease	1.97e-06	2.34e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTM1—coronary artery disease	1.97e-06	2.34e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LPL—coronary artery disease	1.97e-06	2.33e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCA1—coronary artery disease	1.96e-06	2.32e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—coronary artery disease	1.96e-06	2.32e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PIK3CA—coronary artery disease	1.96e-06	2.32e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—C3—coronary artery disease	1.95e-06	2.31e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RPS6KB1—coronary artery disease	1.95e-06	2.31e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MEF2C—coronary artery disease	1.95e-06	2.31e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—coronary artery disease	1.95e-06	2.3e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGF2—coronary artery disease	1.94e-06	2.3e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LPL—coronary artery disease	1.94e-06	2.29e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOB—coronary artery disease	1.92e-06	2.28e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ITGB3—coronary artery disease	1.9e-06	2.25e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT1—coronary artery disease	1.9e-06	2.25e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGT1—coronary artery disease	1.9e-06	2.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—JAK2—coronary artery disease	1.89e-06	2.24e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GPX1—coronary artery disease	1.89e-06	2.24e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HIF1A—coronary artery disease	1.86e-06	2.21e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—JAK2—coronary artery disease	1.86e-06	2.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AGT—coronary artery disease	1.86e-06	2.2e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF1—coronary artery disease	1.85e-06	2.19e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PIK3CA—coronary artery disease	1.85e-06	2.19e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PPP2CA—coronary artery disease	1.85e-06	2.19e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BCL2—coronary artery disease	1.84e-06	2.18e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CD36—coronary artery disease	1.84e-06	2.18e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LPL—coronary artery disease	1.84e-06	2.17e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—coronary artery disease	1.82e-06	2.15e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOE—coronary artery disease	1.82e-06	2.15e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPP2CA—coronary artery disease	1.82e-06	2.15e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCD—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—coronary artery disease	1.8e-06	2.14e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOA1—coronary artery disease	1.8e-06	2.13e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—coronary artery disease	1.79e-06	2.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KDR—coronary artery disease	1.78e-06	2.11e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—coronary artery disease	1.78e-06	2.11e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—coronary artery disease	1.77e-06	2.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PIK3CA—coronary artery disease	1.77e-06	2.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—C3—coronary artery disease	1.77e-06	2.1e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAPK14—coronary artery disease	1.77e-06	2.1e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTHFR—coronary artery disease	1.74e-06	2.07e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ESR1—coronary artery disease	1.74e-06	2.06e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—coronary artery disease	1.74e-06	2.06e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PPP2CA—coronary artery disease	1.72e-06	2.04e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—F2—coronary artery disease	1.72e-06	2.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FN1—coronary artery disease	1.72e-06	2.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6ST—coronary artery disease	1.71e-06	2.02e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTP1—coronary artery disease	1.7e-06	2.02e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NFKBIA—coronary artery disease	1.7e-06	2.01e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCD—coronary artery disease	1.69e-06	2e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HIF1A—coronary artery disease	1.69e-06	2e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARGC1A—coronary artery disease	1.69e-06	2e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AGT—coronary artery disease	1.68e-06	1.99e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMOX1—coronary artery disease	1.68e-06	1.99e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—coronary artery disease	1.66e-06	1.97e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CAT—coronary artery disease	1.66e-06	1.96e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AGT—coronary artery disease	1.66e-06	1.96e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTHFR—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOE—coronary artery disease	1.65e-06	1.95e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—coronary artery disease	1.65e-06	1.95e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KIT—coronary artery disease	1.64e-06	1.94e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—coronary artery disease	1.64e-06	1.94e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOA1—coronary artery disease	1.63e-06	1.93e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—coronary artery disease	1.63e-06	1.93e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOE—coronary artery disease	1.62e-06	1.92e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KDR—coronary artery disease	1.62e-06	1.91e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOB—coronary artery disease	1.61e-06	1.91e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAPK14—coronary artery disease	1.61e-06	1.9e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOA1—coronary artery disease	1.6e-06	1.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—coronary artery disease	1.6e-06	1.89e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—coronary artery disease	1.59e-06	1.88e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PIK3CA—coronary artery disease	1.58e-06	1.87e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HIF1A—coronary artery disease	1.58e-06	1.87e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GSK3B—coronary artery disease	1.58e-06	1.87e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ESR1—coronary artery disease	1.57e-06	1.87e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTM1—coronary artery disease	1.57e-06	1.85e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—POMC—coronary artery disease	1.56e-06	1.85e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CREB1—coronary artery disease	1.56e-06	1.85e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—F2—coronary artery disease	1.56e-06	1.84e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FN1—coronary artery disease	1.56e-06	1.84e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6ST—coronary artery disease	1.55e-06	1.83e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOE—coronary artery disease	1.54e-06	1.82e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LPL—coronary artery disease	1.54e-06	1.82e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NFKBIA—coronary artery disease	1.54e-06	1.82e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.54e-06	1.82e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL2—coronary artery disease	1.53e-06	1.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6R—coronary artery disease	1.52e-06	1.81e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOA1—coronary artery disease	1.52e-06	1.8e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—coronary artery disease	1.51e-06	1.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1—coronary artery disease	1.5e-06	1.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GPX1—coronary artery disease	1.5e-06	1.78e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KIT—coronary artery disease	1.49e-06	1.76e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CD36—coronary artery disease	1.46e-06	1.73e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—coronary artery disease	1.45e-06	1.72e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6ST—coronary artery disease	1.45e-06	1.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPP2CA—coronary artery disease	1.44e-06	1.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—coronary artery disease	1.43e-06	1.7e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GSK3B—coronary artery disease	1.43e-06	1.69e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SERPINE1—coronary artery disease	1.43e-06	1.69e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—POMC—coronary artery disease	1.42e-06	1.68e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CREB1—coronary artery disease	1.42e-06	1.68e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—coronary artery disease	1.41e-06	1.67e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—POMC—coronary artery disease	1.39e-06	1.65e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KIT—coronary artery disease	1.39e-06	1.64e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL2—coronary artery disease	1.39e-06	1.64e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTHFR—coronary artery disease	1.38e-06	1.64e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6R—coronary artery disease	1.38e-06	1.64e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF2—coronary artery disease	1.38e-06	1.64e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MAPK1—coronary artery disease	1.37e-06	1.62e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1—coronary artery disease	1.36e-06	1.61e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—coronary artery disease	1.36e-06	1.61e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GSK3B—coronary artery disease	1.33e-06	1.58e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—JAK2—coronary artery disease	1.32e-06	1.57e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CREB1—coronary artery disease	1.32e-06	1.57e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AGT—coronary artery disease	1.32e-06	1.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SERPINE1—coronary artery disease	1.29e-06	1.53e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6R—coronary artery disease	1.29e-06	1.53e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—coronary artery disease	1.29e-06	1.53e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOE—coronary artery disease	1.29e-06	1.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—coronary artery disease	1.29e-06	1.52e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOA1—coronary artery disease	1.27e-06	1.51e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—coronary artery disease	1.27e-06	1.51e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—MAPK1—coronary artery disease	1.26e-06	1.49e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF2—coronary artery disease	1.25e-06	1.48e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MAPK1—coronary artery disease	1.24e-06	1.47e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—coronary artery disease	1.24e-06	1.46e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.22e-06	1.44e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—coronary artery disease	1.22e-06	1.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—coronary artery disease	1.21e-06	1.43e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SERPINE1—coronary artery disease	1.21e-06	1.43e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—JAK2—coronary artery disease	1.2e-06	1.42e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PIK3CA—coronary artery disease	1.19e-06	1.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF2—coronary artery disease	1.17e-06	1.38e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CASP3—coronary artery disease	1.16e-06	1.37e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—coronary artery disease	1.15e-06	1.37e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCND1—coronary artery disease	1.13e-06	1.33e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—coronary artery disease	1.12e-06	1.33e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—JAK2—coronary artery disease	1.12e-06	1.33e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—coronary artery disease	1.11e-06	1.32e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—POMC—coronary artery disease	1.11e-06	1.31e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—coronary artery disease	1.1e-06	1.3e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PIK3CA—coronary artery disease	1.1e-06	1.3e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—coronary artery disease	1.09e-06	1.29e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PIK3CA—coronary artery disease	1.08e-06	1.27e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—coronary artery disease	1.05e-06	1.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CASP3—coronary artery disease	1.05e-06	1.24e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—coronary artery disease	1.03e-06	1.22e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCND1—coronary artery disease	1.02e-06	1.21e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—coronary artery disease	1.01e-06	1.2e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—coronary artery disease	9.91e-07	1.17e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—coronary artery disease	9.82e-07	1.16e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PIK3CA—coronary artery disease	9.77e-07	1.16e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—coronary artery disease	9.7e-07	1.15e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—coronary artery disease	9.69e-07	1.15e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—coronary artery disease	9.65e-07	1.14e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—coronary artery disease	9.52e-07	1.13e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—coronary artery disease	9.01e-07	1.07e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—coronary artery disease	8.95e-07	1.06e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—coronary artery disease	8.9e-07	1.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAPK1—coronary artery disease	8.84e-07	1.05e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—coronary artery disease	8.79e-07	1.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—coronary artery disease	8.17e-07	9.68e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAPK1—coronary artery disease	8.01e-07	9.49e-06	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—coronary artery disease	7.98e-07	9.45e-06	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PIK3CA—coronary artery disease	7.67e-07	9.08e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—coronary artery disease	7.62e-07	9.03e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MAPK1—coronary artery disease	7.48e-07	8.85e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PIK3CA—coronary artery disease	6.95e-07	8.24e-06	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PIK3CA—coronary artery disease	6.84e-07	8.1e-06	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—coronary artery disease	6.79e-07	8.04e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PIK3CA—coronary artery disease	6.49e-07	7.68e-06	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—coronary artery disease	6.26e-07	7.42e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—coronary artery disease	6.16e-07	7.29e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—coronary artery disease	5.74e-07	6.8e-06	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—coronary artery disease	5.68e-07	6.73e-06	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—coronary artery disease	5.59e-07	6.62e-06	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PIK3CA—coronary artery disease	5.43e-07	6.43e-06	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—coronary artery disease	5.3e-07	6.28e-06	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—coronary artery disease	4.44e-07	5.26e-06	CbGpPWpGaD
